Adaptive Biotechnologies Corp Capital Reinvestment Ratio
Adaptive Biotechnologies Corp capital reinvestment ratio. Adaptive Biotechnologies Corp (ADPT) has a Capital Reinvestment Ratio of 0.01x as of March 2019, meaning it reinvests 0% of its operating cash flow ($278.30 Million) in capital expenditures ($3.83 Million). Check Adaptive Biotechnologies Corp investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Adaptive Biotechnologies Corp (2019–2019)
Capital reinvestment ratio of Adaptive Biotechnologies Corp from 2019 to 2019. This chart tracks Adaptive Biotechnologies Corp's Capital Reinvestment Ratio across 1 annual periods. Also explore Adaptive Biotechnologies Corp annual equity growth to track the company's year-over-year net asset growth rate.
Adaptive Biotechnologies Corp Capital Reinvestment Ratio by Year (2019–2019)
Adaptive Biotechnologies Corp capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see ADPT cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.05x | $205.40 Million | $11.20 Million | — |